DGAP-News: Senvion GmbH / Key word(s): IPO
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.
Senvion sets price range for private placement between EUR 20.00 and EUR 23.50 per share
- Placement period begins 07 March 2016 and is expected to end on 17 March 2016
- First day of trading planned for 18 March 2016
- Total placement of up to 29.9 million shares, including potential over-allotments of 3.9 million shares (15% of the base offer).
- Free-float after private placement expected to be approximately 46% of Senvion's outstanding share capital, assuming full placement of over-allotment shares
- Price range implies market capitalization of approximately EUR 1,300 million to EUR 1,530 million
Hamburg: Senvion Group ("Senvion") and its owners Centerbridge and Arpwood have today announced the price range for Senvion shares in the planned private placement at EUR 20.00 to EUR 23.50 per share. The price range was determined on behalf of the company by the existing shareholders together with Deutsche Bank, J.P. Morgan and Citigroup as Joint Global Coordinators and Joint Bookrunners.
Senvion is offering up to 29.9 million shares from the holdings of the existing shareholders in the private placement including potential over-allotments of 3.9 million shares (15% of the base offer of 26.0 million shares). The placement price per share and the final number of shares to be sold are expected to be determined, based on the order book prepared during the book building process, on or about 17 March 2016. Up to 3.9 million additional shares may be placed with investors in connection with potential over-allotments. The private placement is exclusively addressed to institutional investors and consists of a private placement in the United States to qualified institutional buyers and a private placement to institutional investors outside of the United States.
Jürgen Geissinger, CEO of Senvion, said: "Access to the capital markets will support Senvion's growth path and enhance our company's global profile. As an independent company, we will continue to invest in innovation and developing client relationships as we pursue our strategy to expand into new markets."
Assuming all potential over-allotment shares are placed, the free float following the private placement is expected to amount to approximately 46% of Senvion's issued and outstanding share capital.
BofA Merrill Lynch, Barclays, Berenberg and Morgan Stanley are acting as Joint Bookrunners. Raiffeisen Bank International and Banco Santander are acting as Co-Managers. Rothschild is acting as financial adviser to Senvion.
Certain statements in this press release are forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. No one undertakes any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. You should not place any undue reliance on forward-looking statements which speak only as of the date of this press release. Statements contained in this press release regarding past trends or events should not be taken as representation that such trends or events will continue in the future. The cautionary statements set out above should be considered in connection with any subsequent written or oral forward-looking statements that Senvion S.à r.l. or Senvion S.A. (the "Company"), or persons acting on its behalf, may issue.
These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of Company in the United States, Germany or any other jurisdiction. The Securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Securities of the Company have not been, and will not be, registered under the Securities Act.
In the United Kingdom, this document is only being distributed to and is only directed at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.
Neither the Company nor any of its shareholders intend to make any public offer of shares in the Company in the United States, Germany or any other jurisdiction. It is only intended that shares will be placed with qualified investors and less than 150 non-qualified investors per EEA member state in the Federal Republic of Germany and certain other jurisdictions and subsequently admitted to trading on the regulated market segment (regulierter Markt) of the Frankfurt Stock Exchange with simultaneous admission to the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange. The Listing will be made on the basis of a prospectus that must be published promptly upon approval by the Commission de Surveillance du Secteur Financier (CSSF) and will be available free of charge from the Company, 25C, boulevard Royal, L-2449 Luxembourg, Grand Duchy of Luxembourg, or on the Company's website www.senvion.com.
In any EEA Member State other than the Federal Republic of Germany that has implemented Directive 2003/71/EC (together with any amendment and any applicable implementing measures in any Member State, the "Prospectus Directive") this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.
Document title: 2016_03_07_Senvion_Price Range
- Products & Services
- Jobs & Careers